Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

Circulomics Awarded $1.5M Grant

The NIGMS has awarded Circulomics a $1.5M SBIR Phase II grant to develop a new single molecule platform for sample quality analysis, building on their pre-existing PicoSep technology.